Short answer
Indivior Pharmaceuticals, Inc. (INDV) filed an 8-K current report with the SEC on March 12, 2026 reporting Item 8.01 (Other Events). Indivior launching convertible senior notes due 2031, pricing expected imminently (March 12, 2026 announcement).
Indivior Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Indivior launching convertible senior notes due 2031, pricing expected imminently (March 12, 2026 announcement)
- Convertible notes create potential future equity dilution upon conversion into common stock
- Deal size and coupon rate not yet disclosed in this filing: key terms pending final pricing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Indivior Pharmaceuticals, Inc. 8-K filings
Get the next INDV 8-K as it lands
Follow INDV for push alerts, or ask the research agent what this filing means.